A Injection Pen Market Analysis and Forecast to 2031: By Product Type (Disposable, Reusable), Therapy (Diabetes, Growth Hormone, Osteoporosis, Fertility

Injection Pen Market Analysis and Forecast to 2031: By Product Type (Disposable, Reusable), Therapy (Diabetes, Growth Hormone, Osteoporosis, Fertility, Auto-immune Diseases, Cancer, Others), End User (Home-Care Settings, Hospitals & Diagnostic Clinics), and Region

The injection pen market was valued at USD 37.8 billion in 2021 and it is anticipated to grow further to USD 75.7 billion by 2031, at a CAGR of 7.2% during the forecast period.


The medication is injected into the body using injection pens. They are employed to administer insulin to the patient. Patients can adhere to the prescribed treatment plan with the aid of injectable pens. This method has assisted in enhancing the patient's quality of life and lowering healthcare costs. The injection pen approach is a self-management treatment option for multiple sclerosis and diabetes that is widely used by top pharmaceutical businesses as a drug delivery system. An injection pen has an insulin cartridge, a disposable pen, a needle, and a dial for dosage measurement.

Market Trends and Drivers

In recent years, there has been a dramatic rise in the prevalence of chronic illnesses. Multiple sclerosis, diabetes, osteoporosis, cardiovascular disease (CVD), and other illnesses call for the administration of injectable medications on a daily or weekly basis. Due to the frequent drug administration, injector pens are the best choice for chronic disorders. Injection pens have become the new standard for injectable medicine delivery methods. Their ease of use, dependability, and capacity to be provided by the patient alone without the assistance of a doctor have caused their popularity to grow. In order to effectively manage the expanding patient population and improve patient compliance with therapies, injectable pen technologies have come under more scrutiny as a result of the rising prevalence of chronic diseases.

Market Restraints and Challenges

Devices for injecting are not the only options available. The primary deterrents for using injectable pens are fear of needle sticks and harm. Therefore, there are many needle-free devices that have the extra benefit of not causing needle fear, which is a major barrier to the increased use of injectable medication therapies. Children's and adults' non-complacency is mostly related to the discomfort of the daily injections and the demands of long-term therapy. Additionally, because the dose cannot be controlled, insulin pen therapy is seen to result in hyperglycemia in certain patients. Due to their capability to execute automated insulin suspension and reduce the danger of hypoglycemia, insulin pumps have therefore replaced insulin pens in the treatment of diabetes in Europe.

Global Injection Pen Market Segmental Overview

The report analyses the global injection pen market based on the product type, therapy, end user, and region.

Global Injection Pen Market by Product Type

Based on the product type, it is segmented into disposable injection pen and reusable injection pen. The disposable injection pen segment is anticipated to dominate the market during the forecast period. The key factors such as the low danger of infection or contamination of the medicine, good patient compliance, and ease of use is boosting the growth of the market.

Global Injection Pen Market by Therapy

Based on the therapy, it is segmented into diabetes, growth hormone, osteoporosis, fertility, auto-immune diseases, cancer, and other therapies. The diabetes segment is anticipated to dominate the market during the forecast period. The key factors such as high prevalence of diabetes coupled with increasing awareness of insulin pens among diabetic patients, growing elderly population, and the growing availability of insulin pens in the market are boosting the growth of the market.

Global Injection Pen Market by End User

Based on the end user, it is segmented into home care settings and hospitals & diagnostic clinics. The home care settings segment is anticipated to dominate the market during the forecast period. Some of the primary factors boosting the growth of the market are expanding elderly population, convenience of drug administration, rising prevalence of chronic diseases, technological advancements, and advantageous reimbursement situations.

Geographical Analysis of the Global Injection Pen Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America region dominated the injection pen market during the forecast period. The growth of the market is primarily attributed to the increasing prevalence of diabetes, favorable reimbursement scenario, and the increasing number of awareness programs.

Major Players in the Global Injection Pen Market

The major players studied in the market are COVID-19 Impact

In individuals with COVID-19, diabetes has been directly linked to disease severity and mortality. This fact is supported by the rising morbidity and mortality rates that have been associated with inflammation, hypercoagulation, and weakened immune systems. Both hypoglycemia and hyperglycemia are indicators of worse outcomes in individuals who are hospitalized. To lessen the risk of severe COVID-19, individuals with diabetes and SARS-CoV-2 infection should strive for optimal glycemic management. With regard to treating asymptomatic and non-critically ill COVID-19 diabetic patients, both insulin and GLP-1RAs have demonstrated excellent glucose-lowering and anti-inflammatory benefits in type 2 diabetes patients. In order to change the dosage of insulin or anti-diabetic medications and conduct strict glucose monitoring, customized therapies for diabetes management are now required. For accurate tracking and ideal diabetes control, more people are using insulin pens, insulin pumps, and continuous glucose monitors. Diabetes management makes extensive use of injection pens. Therefore, any change in the total demand for products and services would inevitably have an effect on these.


The COVID-19 pandemic had no effect on the market for injectable pens. Patients who were already utilizing injectable pens for a variety of medicines kept doing so throughout the pandemic. However, mobility limitations, closed borders, and a drop in overall trade damaged the supply chain for injection pens. Patients with COVID-19 infection who underwent therapy have a greater risk of developing diabetes. Therefore, if the prevalence of diabetes rises, so will the demand for injectable pens.

Recent Developments

• April 2020, Sanofi received FDA approval for a new Dupixent prefilled pen for use in asthma, atopic dermatitis, and chronic rhinosinusitis with nasal polyposis for at-home administration.
• June 2019, Sanofi received approval in Europe for Toujeo Solo Star Pens.
• January 2019, Merck KGaG launched Pergoveris a gonadotropin injection pen for fertility treatment.
• January 2019, BD, a leading global medical technology company, announced the U.S. Food and Drug Administration 510(k) clearance of its second-generation BD Nano pen needle, designed for more reliable subcutaneous injection depth.
• May 2018, Hindustan Syringes and Medical Devices one of the largest manufacturers of Disposable Syringes in the World and the largest for Auto Disposable syringes launched most revolutionary and pioneering. India’s First “Made in India” Dispovan Insulin Pen Needle” to provide better comfort for people better comfort for people with diabetes at the 4^th Medical Expo Indore 2018.

Frequently Asked Questions

Q1. How big is the Injection Pen market?Ans. The global Injection Pen market size was USD 37.8 Billion in 2021 and is anticipated to reach USD 75.7 Billion in 2031, growing at a rate of 7.2% from 2022 to 2031.
Q2. What is the Injection Pen market growth rate?Ans. The growth rate of the Injection Pen market is 7.2%.
Q3. Which region holds a major market share for the Injection Pen market?Ans. North America holds a major market share of the Injection Pen market in 2021.
Q4. Which segment accounted for the largest Injection Pen market share?Ans. By end user, home-care settings segment accounted for the largest Injection Pen market share.
Q5. Who are the key players in the Injection Pen market?
Q6. What are the factors driving the Injection Pen market growth?Ans. The major factors driving the growth of the market are the growing healthcare market in emerging countries.
Q7. What are the key growth strategies of Injection Pen market players?Ans. The key growth strategies of Injection Pen market players are product launch and product approval.
Q8. Which region will provide more business opportunities for the Injection Pen market during the forecast period?Ans. The Asia-Pacific region will provide more business opportunities for the Injection Pen market during the forecast period.

Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.